Catalyst Wire Dossier Catalyst Wire Dossier

rh-endostatin

recombinant human endostatin
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for rh-endostatin, covering 2013-12-04 to 2025-12-29. Get the full timeline:

Most recent: Clinical Trial Update: Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma [Phase 1, Phase 2]

See pricing